Trevena
TRVN
#11371
Rank
C$0 M
Marketcap
C$0.0007166
Share price
0.00%
Change (1 day)
-94.90%
Change (1 year)

Earnings for Trevena (TRVN)

Earnings in 2024 (TTM): -C$41.69 Million

According to Trevena's latest financial reports the company's current earnings are C$0.54 Million. In 2023 the company made an earning of -C$52.07 Million, an increase over its 2022 earnings that were of -C$75.13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevena from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$41.69 Million-19.94%
2023 -C$52.07 Million-30.69%
2022 -C$75.13 Million1.38%
2021 -C$74.11 Million78.04%
2020 -C$41.63 Million21.3%
2019 -C$34.32 Million-13.91%
2018 -C$39.86 Million-59.75%
2017 -C$99.02 Million-31.77%
2016 -C$0.15 Billion101.73%
2015 -C$71.95 Million1.14%
2014 -C$71.14 Million114.83%
2013 -C$33.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
C$15.84 B-35,687.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$9.63 B-21,747.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-C$0.12 Billion 155.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-C$1.12 Billion 2,404.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-C$14.75 Million-66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-C$90 Million 102.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-C$0.9 Billion 1,918.69%๐Ÿ‡บ๐Ÿ‡ธ USA